AAAAAA

   
Results: 1-8 |
Results: 8
T-cell reactivity during azathioprine therapy compared with mycophenolate mofetil therapy
Authors: van Besouw, NM van der Mast, BJ de Kuiper, P Gregoor, PJHS Vaessen, LMB IJzermans, JNM van Gelder, T Weimar, W
Citation: Nm. Van Besouw et al., T-cell reactivity during azathioprine therapy compared with mycophenolate mofetil therapy, TRANSPLAN P, 33(3), 2001, pp. 2239-2240
Pretransplant donor-specific helper T cell reactivity as a tool for tailoring the individual need for immunosuppression.
Authors: van der Mast, BJ van Besouw, NM de Kuiper, P Vaessen, LMB Gregoor, PJHS IJzermans, JNM van Gelder, T Claas, FHJ Weimar, W
Citation: Bj. Van Der Mast et al., Pretransplant donor-specific helper T cell reactivity as a tool for tailoring the individual need for immunosuppression., TRANSPLANT, 72(5), 2001, pp. 873-880
Immunologic monitoring of the beneficial effect of one HLA-DR-shared bloodtransfusion in heart transplant patients
Authors: Vaessen, LMB van Miert, PPMC van der Mast, BJ Doumaid, K Balk, AHMM Boog, CJP Weimar, W
Citation: Lmb. Vaessen et al., Immunologic monitoring of the beneficial effect of one HLA-DR-shared bloodtransfusion in heart transplant patients, J HEART LUN, 19(11), 2000, pp. 1098-1107
A longitudinal study of TGF-beta(1) protein levels in renal allograft recipients converted from CsA to MMF or AZA
Authors: van der Mast, BJ van Besouw, NM de Kuiper, P Vaessen, LMB IJzermans, JNM van Gelder, T Weimar, W
Citation: Bj. Van Der Mast et al., A longitudinal study of TGF-beta(1) protein levels in renal allograft recipients converted from CsA to MMF or AZA, CLIN TRANSP, 14(1), 2000, pp. 66-69
Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced
Authors: van Besouw, NM van der Mast, BJ de Kuiper, P Gregoor, PJHS Vaessen, LMB Ijzermans, JNM van Gelder, T Weimar, W
Citation: Nm. Van Besouw et al., Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced, TRANSPLANT, 70(1), 2000, pp. 136-143
Randomized study on the conversion of treatment with cyclosporine to azathioprine or mycophenolate mofetil followed by dose reduction
Authors: Gregoor, PJHS van Gelder, T van Besouw, NM van der Mast, BJ Ijzermans, JNM Weimar, W
Citation: Pjhs. Gregoor et al., Randomized study on the conversion of treatment with cyclosporine to azathioprine or mycophenolate mofetil followed by dose reduction, TRANSPLANT, 70(1), 2000, pp. 143-148
Mycophenolic acid plasma concentrations in kidney allograft recipients with or without cyclosporin: a cross-sectional study
Authors: Gregoor, PJHS van Gelder, T Hesse, CJ van der Mast, BJ van Besouw, NM Weimar, W
Citation: Pjhs. Gregoor et al., Mycophenolic acid plasma concentrations in kidney allograft recipients with or without cyclosporin: a cross-sectional study, NEPH DIAL T, 14(3), 1999, pp. 706-708
Effect of mycophenolate mofetil on erythropoiesis in stable renal transplant patients is correlated with mycophenolic acid trough levels
Authors: van Besouw, NM van der Mast, BJ Gregoor, PJHS Hesse, CJ IJzermans, JNM van Gelder, T Weimar, W
Citation: Nm. Van Besouw et al., Effect of mycophenolate mofetil on erythropoiesis in stable renal transplant patients is correlated with mycophenolic acid trough levels, NEPH DIAL T, 14(11), 1999, pp. 2710-2713
Risultati: 1-8 |